ASX Announcements
Market Sensitive
Opthea Received A$15.9 Million R&D Tax Incentive
Periodic Reports - Other, Company Administration - Other
- Nov 15, 2024
- 2 pages
Market Sensitive
Chair's Address to Shareholders
Director Appointment/Resignation, Chairman's Address to Shareholders
- Nov 15, 2024
- 4 pages
June
Opthea launches $220 million capital raising, MST on ticket
The biotech has high hopes for a new drug that if successful could treat macular degeneration.
- Sarah Thompson, Kanika Sood and Emma Rapaport
April
Why picking ASX biotechs is mostly for the crazy brave
It’s a space with a reputation for rollercoaster returns and outlandish sales pitches, but some investors get lucky.
- Tom Richardson
October 2022
The cash clues that suggest Dreamworld owner is wildly undervalued
Pengana’s James McDonald is tipping into Aussie names Telix and Opthea, potash producer K+S, and the valuation case for Ardent at 70¢.
- Emma Rapaport
August 2022
Carlyle chases potential four-bagger at biotech Opthea
The Carlyle Group and its newly acquired life sciences arm Abingworth are chasing a four-bagger at Australian eye therapies developer Opthea.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
Eye therapies group Opthea in $US240m funding deal, chases equity leg
It’s a big day for ASX-listed Opthea, an eye therapies developer with a near $500 million market capitalisation.
- Anthony Macdonald, Sarah Thompson and Kanika Sood
October 2020
ASX gains 1.2pc for week; Aussie Broadband soars 91pc
The Australian sharemarket notched up a second week of gains even as the S&P/ASX200 Index fell 0.5 per cent on Friday. Afterpay closed at a record high. Aussie Broadband surged on debut. Tyro gained 6 per cent on a deal with Bendigo Bank.
- Updated
- Robert Guy, Vesna Poljak and William McInnes
ASX gains; Six day winning streak as banks bounce; Link soars
The Australian sharemarket notched up a sixth straight days of gains as banks rallied off their session lows. Carlyle and Pacific Equity Partners offered $5.20 a share for Link. Aware Super raised its bid for OptiComm to $6.50 a share. Bravura bought UK-based Delta for $41.5 million.
- Updated
- Robert Guy, Vesna Poljak and William McInnes
September 2020
Banks rally lifts stocks to best week since mid-August
The sharemarket advanced 1.7 per cent over the week as banks enjoyed a massive rally on Friday. Westpac's 7 per cent surge helped steer the S&P/ASX200 Index 1.5 per cent higher on Friday as the government moved to relax responsible lending rules.
- Robert Guy, Vesna Poljak, Sarah Turner, Luke Housego and Tom Richardson
June 2020
Momentum builds for small cap biotechs
Australian Ethical's Andy Gracey likes companies that have real signs of efficacy and are no longer in the petri dish.
- Yolanda Redrup
November 2019
Healthcare stocks tipped for strong 2020 as clinical trial results pour in
Investors have returned to the big life sciences companies as growth in other sectors has slowed, says Morgans.
- Yolanda Redrup
September 2019
Small cap healthcare stocks surge to billion-dollar plays
Successful results from a handful of emerging biotech companies have shifted investor sentiment about the sector.
- Yolanda Redrup